Who owns Schrodinger, Inc. (SDGR)? Elite investor 13F holders

3 tracked elite investors reported holding Schrodinger, Inc as of 2026-06-30, including Bill & Melinda Gates Foundation Trust, Rubric Capital, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Bill & Melinda Gates Foundation TrustSchrodinger IncSHARE2026-06-302026-08-14 00:00:00113452040.00 USD6981664.000000SharesholdOriginal filing
Rubric CapitalSchrodinger IncSHARE2026-06-302026-08-14 00:00:00104000000.00 USD6400000.000000SharesaddOriginal filing
Tudor InvestmentSchrodinger IncSHARE2026-06-302026-08-14 00:00:006647648.00 USD409086.000000SharesreduceOriginal filing
Gotham Asset ManagementSchrodinger IncSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing
D.E. ShawSchrodinger IncSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown